New classification for identifying HR myeloma based on cytogenetic abnormalities

Made to measure: Choosing the optimal regimen in transplant-eligible NDMM

Revolutionising myeloma treatment through immune profiling

Contribution of constitutional BRCA1 promoter methylation to early-onset and familial breast cancer patients from Pakistan

Predicting tumour mutations from pathology images may help increase personalised medicine utilisation

Advancements in paediatric Acute lymphoblastic leukemia management

Comment: Trial updates from GALAXIES Lung-201 and RELATIVITY-104 in NSCLC

Choosing 1st line TKI Wisely in patients with CML

TROP2 expression measured by QCS is a promising predictor of clinical outcomes in patients with mNSCLC

CAR-T - Choosing Wisely

TARGIT trial in intraoperative radiotherapy

Choosing Wisely for young women with breast cancer: Medical therapy